On this episode of Oncology Data advisor, D. Ross Camidge, MD, PhD, University of Colorado, and Beth Sandy, MSN, CRNP, OCN®, University of Pennsylvania, discuss novel treatments for advanced NSCLC and how to manage adverse events associated with small molecule inhibitors. Listen now!